Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stephen Richard is Director at Anika Therapeutics. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 23, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Stephen Richard reported holding 58,273 shares of Anika Therapeutics (ANIK), worth about $781K at the last close of $13 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Anika Therapeutics ANIK | 58,273 | 58K direct | $13 | $781K | Jun 18, 2026 |
Is this Stephen Richard’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Jun 18, 202610Kdisclosed Jun 23
DetailsOfficial recordOn the latest SEC Form 4, dated Jun 18, 2026, Stephen Richard reported holding 58,273 shares of Anika Therapeutics (ANIK). At the last close of $13 on Nov 13, 2026, that is about $781K. This is the stake disclosed in filings, not a net worth.
